SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Carcinoma Clinical Trial

Official title:
A Multicenter, Open Phase Ib Study to Evaluate the Efficacy and Safety of SCT-I10A in Combination With SCT200 or SCT200 in Combination With Paclitaxel/Docetaxel in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Status Recruiting

Clinical Trial Summary

The study is to explore the efficacy and safety of SCT200 with SCT-I10A or SCT200 combined with paclitaxel/docetaxel in the treatment of recurrent/metastatic head and neck squamous cell carcinoma.

Clinical Trial Description

This multicenter, open phase Ib study focused on evaluating the objective response response rates of SCT200 in combination with SCT-I10A or SCT200 in combination with paclitaxel/docetaxel in patients with recurrent/metastatic head and neck squamous cell carcinoma who had previously received different treatments. ;

Study Design

Related Conditions & MeSH terms

Carcinoma
Carcinoma, Squamous Cell
Head and Neck Squamous Carcinoma
Squamous Cell Carcinoma of Head and Neck

Clinical Trial Details

NCT number	NCT05552807
Study type	Interventional
Source	Sinocelltech Ltd.
Contact	Fuqiang Chen
Phone	18510805834
Email	fuqiang_chen@sinocelltech.com
Status	Recruiting
Phase	Phase 1
Start date	June 15, 2022
Completion date	September 2023

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05039606` - Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma	Phase 2
Recruiting	`NCT06306846` - Neoadjuvant SBRT in Localized Advanced HNSCC	Phase 2
Completed	`NCT04361409` - Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma	Phase 1
Recruiting	`NCT00634595` - Trial of E10A in Head and Neck Cancer	Phase 2